Abstract:The aim of the present study was to compare the bioavailability of escitalopram (CAS 128196-01-0) from two escitalopram oxalate (CAS 219861-08-2) tablets (escitalopram 10 mg tablet as test preparation and 10 mg tablet commercially available original tablet of the drug as reference preparation) in 20 Chinese healthy male volunteers, aged between 19 and 27. The study was conducted according to an open, randomized, single blind, 2-way crossover study design with a wash-out phase of 14 d. Blood samples for pharmacokinetic profiling were taken up to 156 h post-dose, and escitalopram plasma concentrations were determined with a validated liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method. Maximum plasma concentrations (C(max)) of 9.85 +/- 1.79 ng/ml (test) and 9.92 +/- 2.14 ng/ml (reference) were achieved. Areas under the plasma concentration-time curve (AUC(0-infinity)) of 428.40 +/- 140.25 ng x h/ml (test) and 413.73 +/- 144.81 ng x h/ml (reference), AUC(0-t) of 401.33 +/- 120.61 ng x h/ml (test), 385.42 +/- 117.73 ng x h/ml (reference) were calculated. The median T(max) was 4.3 +/- 1.8h, 4.1 +/- 1.5 h for test and reference formulation, respectively. Plasma elimination half-lives (t 1/2) of 36.30 +/- 8.93 h (test), 36.70 +/- 9.99 h (reference) were determined. Both primary target parameters, AUC(0-infinity) and AUC(0-t) were tested parametrically by analysis of variance (ANOVA) and relative bioavailabilities were 105.1 +/- 10.8% for AUC(0-infinity), 104.9 +/- 11.1% for AUC(0-t). Bioequivalence between test and reference preparation was demonstrated for both parameters, AUC(0-infinity) and AUC(0-t). The 90% confidence intervals of the T/R-ratios of logarithmically transformed data were in the generally accepted range of 80%-125%. That means that the test formulation is bioequivalent to the reference formulation for escitalopram.

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Study on Bioequivalence of Ambroxol Hydrochloride Tablets from Domestic and Import

Studies on the Bioequivalence of Domestic Terazosin Tablet in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of domestic and imported bisoproloi tablets

Bioequivalent Study of Citalopram Tablets

Bioequivalence study of fluoxetine capsules in healthy volunteers

Determination of Lorazepam in Plasma by LC/MS/MS and Its Application in the Bioequivalence Study

Bioequivalence Test of Domestic Levetiracetam Tablets in Healthy Volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalence of zopiclone tablet in Chinese healthy volunteers

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers

Bioequivalence and Pharmacokinetics of Zolpidem Tartrate Mouth-dissolving Tablets

Studies on the bioequivalence of two sodium rebeprazole entric tablets in healthy volunteers

Study on Bioequivalence of Risperidone Tablets

Study on bioequivalence of tramadol chloride tablets

Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers